TrademarkDir
IPREVASC
DEAD

Serial Number

77182665

Owner

Canyon Pharmaceuticals, Inc.

Attorney

Ned T. Himmelrich

Filing Date

May 16, 2007

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

IPREVASC Trademark

Serial Number: 77182665

IPREVASC is a trademark filed by Canyon Pharmaceuticals, Inc. on May 16, 2007. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Canyon Pharmaceuticals, Inc. (4 trademarks)

Suite 400
Hunt Valley, MD 21032

Entity Type: 03

Trademark Details

Filing Date

May 16, 2007

Registration Date

Not Registered

Published for Opposition

April 29, 2008

Goods & Services

Anti-thrombotic/anti-coagulant preparation

Filing History

PETITION TO DIRECTOR DENIED
Jul 23, 2009 PCDE
ASSIGNED TO PETITION STAFF
Jun 11, 2009 APET
PETITION TO DIRECTOR RECEIVED
Apr 9, 2009 PCRC
PAPER RECEIVED
Apr 9, 2009 MAIL
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Feb 23, 2009 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Feb 23, 2009 ABN6
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 9, 2009 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 9, 2009 REAP
NOA MAILED - SOU REQUIRED FROM APPLICANT
Jul 22, 2008 NOAM
PUBLISHED FOR OPPOSITION
Apr 29, 2008 PUBO
NOTICE OF PUBLICATION
Apr 9, 2008 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 24, 2008 PREV
ASSIGNED TO LIE
Mar 24, 2008 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 6, 2008 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 20, 2008 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 19, 2008 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 19, 2008 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 20, 2007 GNRN
NON-FINAL ACTION E-MAILED
Aug 20, 2007 GNRT
NON-FINAL ACTION WRITTEN
Aug 20, 2007 CNRT
ASSIGNED TO EXAMINER
Aug 20, 2007 DOCK
NEW APPLICATION ENTERED
May 21, 2007 NWAP

Related Trademarks

More from this Owner

THROMBOEMBOLIC PROTECTION FOR PATIENTS AT RISK OF THROMBOCYTOPENIA

THROMBOEMBOLIC PROTECTION FOR PATIENTS AT RISK OF THROMBOCYTOPENIA

REVASC

REVASC

REVASC

REVASC

REVASC

REVASC

THROMBOEMBOLIC PROTECTION FOR PATIENTS AT RISK OF THROMBOCYTOPENIA

THROMBOEMBOLIC PROTECTION FOR PATIENTS AT RISK OF THROMBOCYTOPENIA